Lightcast Raises $27 Million and Adds Industry Veteran to Accelerate Commercialization of Envisia ™Platform · Proceeds will help enhance workflows and expand single-cell functional assay portfolio · Brad Crutchfield joins as advisor to support early access growth and global launch CAMBRIDGE, England – Lightcast, a pioneering life science tools company focused on functional single-cell analysis, today announced […]
CAMBRIDGE, Mass. and SAN FRANCISCO, Calif. – Kytopen Corp., a leader in non-viral, continuous flow cellular engineering, today announced a Series B financing led by Telegraph Hill Partners, with participation from existing investors. The funding will accelerate Kytopen’s global commercial expansion and drive further adoption of its Flowfect® technology platform across the U.S. and Europe. […]
Funding supports expansion of manufacturing and commercial capacity for SemaCyte microcarrier platform Cambridge, UK: Semarion, a University of Cambridge spin-out company from the Cavendish Laboratory combining materials engineering and cell biology to tackle unmet drug screening needs, today announced it has raised $3.8 million USD (£2.9 million GBP). The fundraise was led by Parkwalk, and […]
Appoints Frederik Decouttere as CEO LAUSANNE, Switzerland — Alithea Genomics, an emerging leader in the field of large-scale RNA sequencing and transcriptomics, announced today the closing of its seed financing round with an additional CHF 3 million ($3.9 million), led by Genku Ventures and joined by Novalis Biotech and Zürcher Kantonalbank as well as several […]
mcPCR enables precise copying of DNA methylation during DNA amplification, overcoming a fundamental limitation of PCR, and unlocks new opportunities for sensitive detection of cancer, chronic disease, and in basic research Launch follows successful close of oversubscribed $15.5 million seed financing led by ARCH Venture Partners Gautam Kollu, former CCO of Grail, joins Board Syndex […]
STOCKHOLM, Sweden — CubaseBio, a biotechnology company founded by pioneers in spatial biology, today announced it has secured €5.9 million in blended financing. The funding comprises a €2 million non-dilutive grant from the European Innovation Council (EIC) Transition program and €3.9 million in private capital and convertibles from Voima Ventures, Nordic Science Investments (NSI), Illumina Ventures, Almi invest, Life Science Invest and […]
TeraView, the pioneer and leader in terahertz technology and solutions, is the first UK and European-based company to list on KOSDAQ, the secondary Korean stock market for small to medium-sized (SME) high-growth, technology and venture companies. TeraView listed on December 9 and supports companies such as NVIDIA, AMD, Intel, Samsung, Ford, Volkswagen and other major […]
New funding accelerates platform development and meets surging demand as pharma and biotech reimagine drug discovery LONDON — Automata, the lab automation company building fully integrated, AI-ready platforms for life sciences, today announced the close of a $45 million Series C funding round led by Dimension with participation from Danaher Ventures, Tru Arrow Partners, Octopus […]
Financing led by US life sciences investor, BroadOak Capital Partners Investment to support expansion of US operations, product development, and cell manufacturing scale-up Cambridge / Edinburgh, UK: Axol Bioscience Ltd. (Axol), a leading provider of induced pluripotent stem cell (iPSC) technologies for drug discovery and disease research, today announced that it has secured $2.8 million (£2.1 […]
Additional $12M financing led by Elevage Medical Technologies and Jonathan Milner alongside existing investors British Business Bank, and GK Goh The funding will accelerate development of eProtein Discovery for full-format antibody expression, purification, and binding validation Cambridge, UK, and Boston MA, USA: Nuclera, the biotechnology company accelerating drug discovery by providing rapid, easy access to functional proteins […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
